Barcelona, Spain

Francisco Javier Clemente Rodriguez


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Francisco Javier Clemente Rodriguez: Innovator in Pharmaceutical Formulations

Introduction

Francisco Javier Clemente Rodriguez is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations for peptide compounds. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Rodriguez's latest patents include a stable pharmaceutical formulation for intravenous or intramuscular administration of active peptide compounds. This formulation is characterized by the inclusion of glycine in concentrations ranging from 10 to 60 mM, along with an aqueous solution of hydrochloric acid to adjust the pH between 3.0 and 4.2. Another important patent is a procedure for obtaining the somatostatin analog, octreotide, through solid phase synthesis on polymer supports. This procedure involves several intricate steps, including the construction of a seven amino acid linear peptide and the removal of protective groups to yield octreotide.

Career Highlights

Rodriguez is currently employed at Lipotec, S.A., where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficacy and stability of peptide-based medications, which are crucial for various therapeutic applications.

Collaborations

Some of his notable coworkers include Berta Ponsati Obiols and Gemma Jodas Farres. Their collaborative efforts contribute to the advancement of pharmaceutical research and development.

Conclusion

Francisco Javier Clemente Rodriguez stands out as a key figure in the pharmaceutical industry, with his innovative patents paving the way for improved medical treatments. His contributions reflect a commitment to advancing healthcare through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…